Last Price
0.321
Today's Change
-0.01 (3.02%)
Day's Change
0.315 - 0.33
Trading Volume
122,100
Overview
Market Cap
9 Million
Shares Outstanding
30 Million
Avg Volume
13,321,695
Avg Price (50 Days)
0.42
Avg Price (200 Days)
0.34
PE Ratio
-0.84
EPS
-0.38
Earnings Announcement
20-Sep-2024
Previous Close
0.33
Open
0.33
Day's Range
0.315 - 0.33
Year Range
0.19 - 1.58
Trading Volume
122,100
Price Change Highlight
1 Day Change
-2.96%
5 Day Change
-2.11%
1 Month Change
-13.30%
3 Month Change
18.81%
6 Month Change
14.98%
Ytd Change
-28.71%
1 Year Change
-68.26%
3 Year Change
-96.99%
5 Year Change
-90.65%
10 Year Change
-97.23%
Max Change
-99.39%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
2
3
CEO Morning Brief
4
CEO Morning Brief
Scaramucci Expects Bitcoin Record on Rate Cuts, Clearer US Rules
5
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
